Literature DB >> 18054292

Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry.

Ursula Turpeinen1, Esa Hämäläinen, Ulf-Håkan Stenman.   

Abstract

Measurement of serum aldosterone is clinically important in the diagnosis of hypertension. While isotope dilution gas chromatography-mass spectrometry (ID-GC-MS) provides reliable results, it requires derivatization and is lengthy and time-consuming. Detection by liquid chromatography-mass spectrometry (LC-MS) is a potentially superior method. The analysis utilizes 0.5mL of serum. The samples were extracted with dichloromethane-ether. The extract was evaporated to dryness and aldosterone was analyzed by LC-MS/MS operating in the negative mode ESI after separation on a reversed-phase column. Aldosterone was also measured by RIA. The calibration curves for analysis of serum aldosterone exhibited consistent linearity and reproducibility in the range of 60-3000pmol/L. Interassay CVs were 4.3-7.5% at aldosterone concentrations of 97-993pmol/L. The lower limit of quantitation (LOQ) was 30pmol/L (signal to noise ratio=10). The mean recovery of the analyte added to serum ranged from 95 to 102%. The regression equation by LC-MS/MS (x) and RIA (y) method was: y=1.33x+185 (r=0.95; n=124). Sensitivity and specificity of the LC-MS/MS method for serum aldosterone offer advantages over GC-MS by eliminating derivatization. The novel method is rapid, reliable and simple to perform with a routine LC-MS/MS spectrometer. The sensitivity is adequate for patient samples. Aldosterone concentrations reported by nonextraction RIA were consistently higher than those produced by LC-MS/MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054292     DOI: 10.1016/j.jchromb.2007.11.005

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  10 in total

Review 1.  Principles and clinical applications of liquid chromatography - tandem mass spectrometry for the determination of adrenal and gonadal steroid hormones.

Authors:  A E Kulle; M Welzel; P-M Holterhus; F G Riepe
Journal:  J Endocrinol Invest       Date:  2011-07-05       Impact factor: 4.256

Review 2.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Authors:  Phillip J Monaghan; Brian G Keevil; Peter J Trainer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

3.  Quantitation of Aldosterone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

Authors:  J Grace van der Gugten; Daniel T Holmes
Journal:  Methods Mol Biol       Date:  2022

4.  The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy.

Authors:  Graeme Eisenhofer; Max Kurlbaum; Mirko Peitzsch; Georgiana Constantinescu; Hanna Remde; Manuel Schulze; Denise Kaden; Lisa Marie Müller; Carmina T Fuss; Sonja Kunz; Sylwia Kołodziejczyk-Kruk; Sven Gruber; Aleksander Prejbisz; Felix Beuschlein; Tracy Ann Williams; Martin Reincke; Jacques W M Lenders; Martin Bidlingmaier
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

5.  Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status.

Authors:  Graeme Eisenhofer; Mirko Peitzsch; Denise Kaden; Katharina Langton; Christina Pamporaki; Jimmy Masjkur; George Tsatsaronis; Anastasios Mangelis; Tracy A Williams; Martin Reincke; Jacques W M Lenders; Stefan R Bornstein
Journal:  Clin Chim Acta       Date:  2017-05-04       Impact factor: 3.786

6.  Validated low-volume aldosterone immunoassay tailored to GCLP-compliant investigations in small sample volumes.

Authors:  J Schaefer; B B Burckhardt; J Tins; A Bartel; S Laeer
Journal:  Pract Lab Med       Date:  2017-07-27

7.  Developing an ultra-performance liquid chromatography-tandem mass spectrometry for detecting aldosterone in human plasma.

Authors:  Wenbin Lin; Zhenrong Yao; Yuzhe Li; Zhihao Liao; Jiahao Xiao; Yonghong Chen; Pinning Feng; Wenjia Gan
Journal:  J Clin Lab Anal       Date:  2021-09-30       Impact factor: 2.352

8.  A novel bead-based fluorescence immunoassay for aldosterone.

Authors:  Min Sun; Chao Liu
Journal:  J Biomed Res       Date:  2011-05

9.  Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism.

Authors:  Stefan Pilz; Andreas Tomaschitz; Vinzenz Stepan; Barbara Obermayer-Pietsch; Astrid Fahrleitner-Pammer; Natascha Schweighofer; Horst R Portugaller; Harald Sourij; Harald Dobnig; Andreas Meinitzer; Thomas R Pieber
Journal:  BMC Endocr Disord       Date:  2009-04-07       Impact factor: 2.763

10.  Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS.

Authors:  Carmina Teresa Fuss; Katharina Brohm; Max Kurlbaum; Anke Hannemann; Sabine Kendl; Martin Fassnacht; Timo Deutschbein; Stefanie Hahner; Matthias Kroiss
Journal:  Eur J Endocrinol       Date:  2021-01       Impact factor: 6.664

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.